STATEMENT: Advocates call for a persistent advocacy for the implementation of the RPRH Law

June 1, 2017

On May 26, 2017, the Supreme Court (SC) finally released its August 26 resolution clarifying that the TRO only covers Implanon and Implanon NXT, and that it never meant to cover other contraceptives that are “unquestionably non-abortifacient”. The SC also added that the TRO is deemed lifted once the FDA follows its ruling and provides an opportunity for opportunity for the oppositors to comment on the registration of Implanon and Implanon NXT.

The Supreme Court maintained that the FDA must develop procedures for the screening, evaluation, and approval of contraceptive drugs and devices and modified its August 2016 resolution by stating that FDA decisions may be appeals to the Office of the President.

The Purple Ribbon for Reproductive Health views this recent modification as a means to a better end—a continued progress in the implementation of sexual and reproductive health and rights (SRHR) policies from the national government to the local government units.

We urge the FDA to comply with the Supreme Court resolution to immediately resolve the contraceptive use of said implants.

The Purple Ribbon for Reproductive Health urges stakeholders to strongly advocate for the implementation of the Responsible Parenthood and Reproductive Health (RPRH) Law. The RPRH Law is a landmark legislation that not only covers access to family planning, but also institutionalizes programs for maternal healthcare, age-appropriate sexuality and reproductive health education, as well as funding to support these programs.

The Purple Ribbon for Reproductive Health remains committed and vigilant in pushing for the implementation of the RPRH Law and urges all Filipinos to assert their sexual and reproductive health and rights and to do their part in seeing this advocacy through.